Financial & Policy Research Insights

In the first 100 days of the Trump administration, healthcare has shifted...

Get actionable insights into trade disputes, healthcare reform, defense funding, tech regulation, and energy market shifts with Washington Analysis’ comprehensive Q2 2025 outlook.

Get exclusive insights into the lawsuits challenging IEEPA tariffs and what’s next for U.S. trade policy and markets.

This exclusive Washington Analysis call explored the Trump administration’s food policy priorities, featuring an experienced regulatory attorney.

This research explores how potential PBM reform, IRA implementation, and pricing policy shifts may provide moderate tailwinds for retail pharmacy chains like CVS, WBA, and RiteAid in 2025.

Washington Analysis Healthcare Team hosted a conference call with a leading UK-based strategic advisor to understand better the potential...

An exclusive policy event in Washington, D.C., covering key legislative developments in healthcare, consumer goods, Medicaid, Medicare, and RFK Jr.'s Make America Healthy Again priorities.

2025 will bring major healthcare policy shifts, impacting ACA subsidies, Medicare payments, drug pricing, and REITs.

Republicans will have a unified government (White House, House, and Senate) heading into 2025.

With less than 60 days until November 5, can meaningful change still happen, or are we headed for more of the same or worse?